Olanzapine concentrations collected postmortem in patients treated with olanzapine long-acting injection

被引：1
|
作者：
McDonnell, D. P. [1 ]
Detke, H. C. [1 ]
Falk, M. [1 ]
Shatapathy, C. C. [1 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2013年 / 23卷
关键词：
D O I：
10.1016/S0924-977X(13)70776-4
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.3.d.053
引用
收藏
页码：S489 / S490
页数：2
相关论文
共 50 条
  • [31] COST-EFFECTIVENESS OF LONG-ACTING OLANZAPINE VERSUS LONG-ACTING RISPERIDONE IN PATIENTS WITH SCHIZOPHRENIA IN SPAIN
    Dilla, T.
    O'Donohoe, P.
    Moeller, J.
    Alvarez, M.
    Sacristan, J.
    San, L.
    Happich, M.
    Tockhorn, A.
    VALUE IN HEALTH, 2011, 14 (07) : A292 - A292
  • [32] Assessing the infrequent oral supplementation of olanzapine long-acting injection in the treatment of schizophrenia
    Ascher-Svanum, H.
    Peng, X.
    Montgomery, W.
    Faries, D. E.
    Lawson, A. H.
    Witte, M. M.
    Novick, D.
    Jemiai, N.
    Perrin, E.
    McDonnell, D. P.
    EUROPEAN PSYCHIATRY, 2011, 26 (05) : 313 - 319
  • [33] Comparison of metabolic parameters during treatment for schizophrenia with olanzapine intramuscular long-acting injection versus olanzapine oral formulation
    Gulliver, A.
    McDonnell, D. P.
    Kryzhanovskaya, L. A.
    Zhao, F.
    Detke, H. C.
    Feldman, P. D.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 152 - 152
  • [34] Postmortem Tissue Concentrations of Olanzapine
    Vance, Christopher
    McIntyre, Iain M.
    JOURNAL OF ANALYTICAL TOXICOLOGY, 2009, 33 (01) : 15 - 26
  • [35] Olanzapine long-acting injection: post-injection delirium/sedation syndrome and cardiovascular disorders
    Bergdoll, E.
    Pinzani, V.
    Nishikawa, T.
    Grandvuillemin, A.
    Micallef, J.
    Trenque, T.
    Leplay, M.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2016, 30 : 80 - 80
  • [36] Research article Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, I: analysis of cases
    Detke, Holland C.
    McDonnell, David P.
    Brunner, Elizabeth
    Zhao, Fangyi
    Sorsaburu, Sebastian
    Stefaniak, Victoria J.
    Corya, Sara A.
    BMC PSYCHIATRY, 2010, 10
  • [37] Safety and efficacy of olanzapine long-acting injection for up to 6 years in patients with schizophrenia or schizoaffective disorder
    McDonnell, D. P.
    Detke, H. C.
    Choukour, M.
    Landry, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S319 - S320
  • [38] Olanzapine long-acting injection in patients with schizophrenia at risk of relapse: 12-week switching data
    Detke, H.
    McDonnell, D.
    Andersen, S.
    Watson, S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S435 - S435
  • [39] OLANZAPINE: A REVIEW OF RAPID AND LONG-ACTING PARENTERAL FORMULATIONS
    Owen, R. T.
    DRUGS OF TODAY, 2010, 46 (03) : 173 - 181
  • [40] Long-acting injectable antipsychotics: focus on olanzapine pamoate
    Lindenmayer, J. P.
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2010, 6 : 261 - 267
12345